Recent News for SNGX - Soligenix, Inc.

Date	Title
May 16	Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
May 14	SNGX: Second Confirmatory Phase 3 Trial of HyBryte™ in CTCL to Initiate Before End of 2024…
May 13	Soligenix First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 6	Soligenix to Present at Upcoming Conferences